Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» diabetes
diabetes
Analysts turn bearish on Roche's taspoglutide prospects
Fierce Biotech
Tue, 06/29/10 - 09:17 am
diabetes
taspoglutide
analysts
Roche
Halozyme says enzyme boosts insulin absorption
Yahoo/AP
Tue, 06/29/10 - 09:14 am
Halozyme
insulin
diabetes
enzymes
GSK backs Avandia again amid renewed pressure for withdrawal
Pharma Times, UK
Tue, 06/29/10 - 09:08 am
GSK
Avandia
diabetes
Why Avandia Will Change The Drug Industry
Forbes
Tue, 06/29/10 - 09:07 am
Avandia
GSK
diabetes
Medtronic's 24-Hour Diabetes Monitors Beat Standard Therapy, Study Shows
Tue, 06/29/10 - 09:06 am
Medtronic
diabetes
glucose monitors
Forest Laboratories says potential diabetic pain drug Radiprodil fails midstage study
Yahoo/AP
Mon, 06/28/10 - 07:03 pm
Forest Labs
diabetes
clinical trials
Radiprodil
Amylin's New Diabetes Drug Well Tolerated By Sufferers
CNBC
Mon, 06/28/10 - 02:59 pm
Amylin
diabetes
Bydureon
type 2 diabetes
Biodel, Arena Pharma: Volume Movers
TheStreet.com
Mon, 06/28/10 - 02:54 pm
Biodel
Arena Pharmaceuticals
diabetes
obesity
Mannkind Falls Following Afrezza Presentation; Hapoalim Reiterates Sell
Barron's
Mon, 06/28/10 - 02:53 pm
MannKind
Afrezza
diabetes
inhaled insulin
Hapoalim
Avandia, Heart Attacks & An Upcoming FDA Meeting
Pharmalot
Mon, 06/28/10 - 01:43 pm
Avandia
heart attacks
GSK
diabetes
FDA
Actos
Takeda
Artificial Pancreas Improves Overnight Glucose Control for Range of Real-Life Situations, Latest Data Show
Mon, 06/28/10 - 12:30 pm
artificial organs
JDRF Artificial Pancreas Project
diabetes
J&J Subsidiary Joins the Diabetes Fray
Seeking Alpha
Mon, 06/28/10 - 09:56 am
diabetes
JNJ
Ortho-McNeil-Janssen
Metabolex
Diamyd Medical
In a New Study, Treatment With JANUMET® (sitagliptin/metformin), Merck's Diabetes Medicine, Resulted In Significantly Greater Blood Sugar Lowering Compared with Pioglitazone
Yahoo/BusinessWire
Sun, 06/27/10 - 11:07 am
Januvia
Merck
pioglitazone
diabetes
type 2 diabetes
Actos
Takeda
Preclinical Results With XOMA 052 in Type 2 Diabetes Presented at American Diabetes Association 70th Scientific Sessions
Yahoo/Globe NewsWire
Sun, 06/27/10 - 10:59 am
XOMA 052
Xoma
diabetes
type 2 diabetes
Improvement in Beta-Cell Function Observed After Three Years of BYETTA(R) Therapy: Data Presented at ADA 2010
Yahoo/PR NewsWire
Sun, 06/27/10 - 10:56 am
Eli Lilly
Amylin
Byetta
diabetes
type 1 diabetes
Meta-Analysis of SYMLIN(R) Clinical Data Showed No Increased Risk of Cardiovascular Adverse Events Associated With SYMLIN Treatment in Patients With Type 2 Diabetes
Yahoo/PR NewsWire
Sun, 06/27/10 - 10:54 am
Symlin
Amylin
diabetes
type 1 diabetes
AFREZZA Suppresses Endogenous Glucose Production More Rapidly Than Currently Available Insulin Therapy
Yahoo/BusinessWire
Sun, 06/27/10 - 10:52 am
Afrezza
MannKind
diabetes
type 2 diabetes
Study Finds BYETTA(R) Use Was Not Associated With Increased Rate of Acute Pancreatitis Compared to Other Antidiabetic Drugs
Trading Markets
Sat, 06/26/10 - 11:19 am
Eli Lilly
Byetta
Amylin
diabetes
Roche’s Taspoglutide Works Better Than Lantus, Byetta in Trials
BusinessWeek
Sat, 06/26/10 - 10:29 am
Roche
taspoglutide
Sanofi
Eli Lilly
Amylin
Byetta
Merck
Januvia
diabetes
Phase 2 data for ultra-long-acting insulin degludec show the potential to effectively lower blood sugar, including when used three times a week
Pharmaceutical Processing
Sat, 06/26/10 - 10:15 am
type 1 diabetes
Novo Nordisk
IDegAsp
diabetes
degludec
BOOST
Pages
« first
‹ previous
…
98
99
100
101
102
103
104
105
106
…
next ›
last »